Anti-Coagulants - Gabon

Gabon

In Gabon, the revenue in the Anti-Coagulants market is projected to reach US$1.27m in 2024.
It is expected to show an annual growth rate (CAGR 2024-2029) of 6.86%, resulting in a market volume of US$1.77m by 2029.
When compared globally, United States will generate the highest revenue with US$16,740.00m in 2024.
In Gabon, the demand for anti-coagulants is rapidly rising due to an aging population and an increasing prevalence of cardiovascular diseases.

Key regions: Australia, Japan, United States, Germany, Europe

Market

Region

Region comparison

Currency

Analyst Opinion

The Anti-Coagulants market in Gabon is experiencing growth due to various factors that are shaping the healthcare industry in the country.

Customer preferences: Patients in Gabon are becoming more aware of the importance of preventing and treating blood clots. This is leading to an increase in demand for Anti-Coagulants drugs. Additionally, the aging population in Gabon is also contributing to the growth of the Anti-Coagulants market as the elderly are more susceptible to blood clots.

Trends in the market: One of the major trends in the Anti-Coagulants market in Gabon is the shift towards newer oral Anti-Coagulants drugs. These drugs are more effective and have fewer side effects than traditional Anti-Coagulants drugs. This trend is expected to continue in the coming years as more patients in Gabon become aware of the benefits of newer oral Anti-Coagulants drugs.

Local special circumstances: Gabon has a relatively small population, and the healthcare industry in the country is still developing. This means that access to healthcare services and drugs can be limited, especially in rural areas. However, the government of Gabon has been investing in healthcare infrastructure in recent years, which is expected to improve access to healthcare services and drugs in the country.

Underlying macroeconomic factors: Gabon is a middle-income country that is heavily dependent on oil exports. The recent decline in oil prices has had an impact on the country's economy, but the government has been implementing economic reforms to diversify the economy and reduce dependence on oil. The healthcare industry is one of the sectors that the government is focusing on, which is expected to drive growth in the Anti-Coagulants market in Gabon in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.